Project Grant R01MH139940

Award Date 5/1/25
Completion Date 2/28/30
Dollars Obligated $795K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $541,080 to conduct a human laboratory study examining the effects of repeated cannabidiol (CBD) administration on the abuse liability and analgesic properties of smoked cannabis. The key objectives are to determine if daily oral CBD alters: 1) the abuse-related and reinforcing effects of smoked cannabis, and 2) the analgesic (pain...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $376,078.00 to The Regents of the University of Colorado (CU) to conduct an experimental study on the antecedents and consequences of cannabis use for coping purposes. The study aims to examine whether cannabis use increases after stress induction among individuals who use cannabis to cope, as well as investigate if social anxiety,...
This federal Project Grant award of $100,267, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research to investigate the developmental effects of cannabinoid exposure, including tetrahydrocannabinol (THC) and cannabidiol (CBD), on neuroinflammation and behavioral outcomes in a zebrafish model system. The research, conducted by the University of Mississippi, aims to define the sensitive developmental...
This Project Grant award from the National Institute of Mental Health (NIMH), under CFDA program 93.242 Mental Health Research Grants, will support research into the neurocircuitry underlying motivated reward-seeking behavior as a coping mechanism for stress. The $606,029 award, effective August 1, 2024 through July 31, 2025, will be administered by the University of Massachusetts Medical School. The key objectives are to investigate how sub-populations of neurons in the medial...
This Project Grant award from the National Institute of General Medical Sciences (CFDA 93.859 Biomedical Research and Research Training) provides $350,000 in funding to Creighton University to investigate the developmental effects of environmental enrichment on the sensitivity to minor cannabinoid drugs such as delta-8-THC and CBD. The key objectives are to 1) determine if adolescent exposure to high- or low-novelty environments can alter the behavioral response to these cannabis-derived...
This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on investigating the effects of early-life cannabinoid exposure on the development of the prefrontal cortex and cognitive behaviors in mice. The total funding amount is $1,433,155, with the award period running from June 1, 2024 to March 31, 2029. The key objectives of this research project are to: 1) reveal the spatial and...
The National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) awarded a $350,000 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to West Virginia University (WVU) to study the effects of cannabidiol (CBD) on driving performance and cognitive function in healthy adults. The 5-year research project aims to determine the dose-dependent effects of CBD on driving ability, drowsiness, sedation, and cognitive function in a...
This $433,710 federal Project Grant award was provided by the National Institutes of Health's National Center for Complementary and Integrative Health (NCCIH) under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award aims to fund complementary and integrative research on the unique and overlapping mechanisms of action of cannabis and kratom constituents, as well as their potential synergistic effects, in mouse models of neuropathic pain,...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Federal Grant Program 93.242 Mental Health Research Grants, provides $760,143 in funding to the University of Maryland, Baltimore to study the interactions between the endocannabinoid system and cholinergic transmission in the hippocampus and their impact on working memory and reward motivation. The research will use animal models and human subjects to investigate the role of acetylcholine and cannabinoid...
This $713,908 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a 5-year study investigating the neural and psychiatric consequences of cannabis use in depressed adolescents. The research aims to understand how cannabis use affects reward and pain neurocircuits, particularly the role of the habenula, and how this may impact depression chronicity in this population. The study will prospectively...

This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $794,696 to the Icahn School of Medicine at Mount Sinai to conduct research on the pathophysiological mechanisms of cannabidiol (CBD) in stress regulation. The study aims to evaluate the effects of CBD on neural reactivity, limbic system function, neuronal viability, and endocrine/behavioral stress responses in a clinical high-risk population of young adults with early life adversity. The award period runs from May 1, 2025 to February 28, 2030, allowing the researchers to investigate the long-term impacts of CBD on stress-related disorders. This research aims to advance the understanding of CBD's therapeutic potential for addressing stress dysregulation, which is a fundamental issue across various psychiatric conditions.

Generated 5/13/25, 4:02 AM